Strategies for the use of Ginkgo biloba extract, EGb 761(®), in the treatment and management of mild cognitive impairment in Asia: Expert consensus

BACKGROUND: Mild cognitive impairment (MCI) is a neurocognitive state between normal cognitive aging and dementia, with evidence of neuropsychological changes but insufficient functional decline to warrant a diagnosis of dementia. Individuals with MCI are at increased risk for progression to dementi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:CNS Neurosci Ther
Main Authors: Kandiah, Nagaendran, Chan, Yee Fai, Chen, Christopher, Dasig, Darwin, Dominguez, Jacqueline, Han, Seol‐Heui, Jia, Jianping, Kim, SangYun, Limpawattana, Panita, Ng, Li‐Ling, Nguyen, Dinh Toan, Ong, Paulus Anam, Raya‐Ampil, Encarnita, Saedon, Nor'izzati, Senanarong, Vorapun, Setiati, Siti, Singh, Harjot, Suthisisang, Chuthamanee, Trang, Tong Mai, Turana, Yuda, Venketasubramanian, Narayanaswamy, Yong, Fee Mann, Youn, Yong Chul, Ihl, Ralf
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2020
Assuntos:
Clinical Guideline
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7816207/
https://ncbi.nlm.nih.gov/pubmed/33352000
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cns.13536
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados